Col. Gregory Gadson, United States Army (Ret.) Appointed New Board Member of MVPvets

Col. Gregory Gadson, United States Army (Ret.). has been appointed to the board of MVPvets, a 501(c)(3) nonprofit organization that assists and prepares transitioning military veterans for meaningful employment in medical device and life science companies.

“We are honored to welcome such a force and advocate for wounded warriors, veterans, and those with disabilities to help further the mission of MVPvets,” said Capt. Derek Herrera, UCMC (Ret.) of Gadson’s new appointment.

Col. Gregory Gadson is a graduate of the United States Military Academy at West Point and served as an Army officer for 25 years. Greg served in every major conflict of the past two decades, including Operations Desert Shield/Storm in Kuwait; Operation Joint Forge in Bosnia-Herzegovina; Operation Enduring Freedom in Afghanistan and Operation Iraqi Freedom. In 2007, during combat operations in Iraq an improvised explosive device (IED) cost him both legs above the knees and normal use of his right arm and hand. Since his injury, he has served as Director of the United States Army Wounded Warrior Program and founded a management consulting business, Patriot Strategies, LLC. Gadson’s experience as a wounded warrior that successfully transitioned back into the civilian workforce will serve as a great resource for fellow wounded veteran MVPvets members who face unique challenges.

Along with Gadson’s new appointment, MVPvets announces the launch of a new program, The Academy, to lead transitioning military veterans through a 6-week long virtual training and career mentorship program beginning this August. Many topics are relevant to military veterans and service members within 6 months of separation and include virtual interviewing, resume writing, goal setting, job search planning, and more. The free program will be led virtually by MVPvets staff and industry mentors from medical device and life science companies. Upon course completion, graduating fellows will be invited to virtually attend The MedTech Conference in October. The MedTech Conference, powered by AdvaMed, will serve as an invaluable resource for fellows to have access to the world’s top medtech executives and innovators, educational programming, and business development opportunities.

“I am excited to be a part of an organization that is adapting its programs virtually to meet the needs of transitioning service members. The Academy and MedTech Conference will help MVPvets in its mission to connect military veterans with engaged mentors and careers in the medical device and life science industries,” said Gadson.

SourceMVPvets

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”